Results 11 to 20 of about 26,123,489 (353)

Designing a vaccine for tuberculosis [PDF]

open access: yesBMJ, 1996
Tuberculosis is a disease of superlatives. Mycobacterium tuberculosis causes more deaths annually than any other infectious agent.1 Globally, it is one of the major pathogens associated with HIV disease.1 The tuberculosis vaccine, BCG, has been given to more people than any other vaccine.2 3 However, although this vaccine confers clear benefit against ...
A S, Malin, D B, Young
openaire   +2 more sources

Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design

open access: yesViruses, 2021
The spike protein in SARS-CoV-2 (SARS-2-S) interacts with the human ACE2 receptor to gain entry into a cell to initiate infection. Both Pfizer/BioNTech’s BNT162b2 and Moderna’s mRNA-1273 vaccine candidates are based on stabilized mRNA encoding prefusion ...
X. Xia
semanticscholar   +1 more source

Vaxign2: the second generation of the first Web-based vaccine design program using reverse vaccinology and machine learning

open access: yesNucleic Acids Res., 2021
Vaccination is one of the most significant inventions in medicine. Reverse vaccinology (RV) is a state-of-the-art technique to predict vaccine candidates from pathogen's genome(s).
E. Ong   +8 more
semanticscholar   +1 more source

SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness

open access: yesNature, 2020
A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic.
K. Corbett   +61 more
semanticscholar   +1 more source

Principles and practical applications of structure-based vaccine design

open access: yesCurrent Opinion in Immunology, 2022
Viral proteins fold into a variety of structures as they perform their functions. Structure-based vaccine design aims to exploit knowledge of an antigen’s architecture to stabilize it in a vulnerable conformation.
P. O. Byrne, J. McLellan
semanticscholar   +1 more source

Immunoinformatics Approach for Epitope-Based Vaccine Design: Key Steps for Breast Cancer Vaccine

open access: yesDiagnostics, 2022
Vaccines are an upcoming medical intervention for breast cancer. By targeting the tumor antigen, cancer vaccines can be designed to train the immune system to recognize tumor cells. Therefore, along with technological advances, the vaccine design process
A. F. Prawiningrum   +2 more
semanticscholar   +1 more source

Susceptibility Analysis in Several Mouse Strains Reveals Robust T-Cell Responses After Mycoplasma pneumoniae Infection in DBA/2 Mice

open access: yesFrontiers in Cellular and Infection Microbiology, 2021
Mycoplasma pneumoniae (Mp) is a highly contagious respiratory pathogen responsible for human community-acquired pneumonia. The number of antibiotic-resistant Mp strains is increasing; therefore, to develop novel therapeutics, it is crucial to precisely ...
Shigeyuki Tamiya   +11 more
doaj   +1 more source

The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design

open access: yesCurrent Opinion in Immunology, 2022
Despite the extraordinary speed and success in SARS-Cov-2 vaccine development, the emergence of variants of concern perplexed the vaccine development community. Neutralizing antibodies waned antibodies waned and were evaded by viral variants, despite the
C. Britto, G. Alter
semanticscholar   +1 more source

Considerations of CD8+ T Cells for Optimized Vaccine Strategies Against Respiratory Viruses

open access: yesFrontiers in Immunology, 2022
The primary goal of vaccines that protect against respiratory viruses appears to be the induction of neutralizing antibodies for a long period. Although this goal need not be changed, recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ...
Toshiro Hirai   +6 more
doaj   +1 more source

Effects of hypoxia on antigen presentation and T cell-based immune recognition of HPV16-transformed cells

open access: yesFrontiers in Immunology, 2022
Attempts to develop a therapeutic vaccine against human papillomavirus (HPV)-induced malignancies have mostly not been clinically successful to date.
Nitya Mohan   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy